Our teams of multidisciplinary investigators with the Cardiovascular Research Center (CVRC) are breaking new ground as we strive to transform scientific findings into real and progressive therapies to combat cardiovascular diseases. We are continuously growing our cutting-edge translational research laboratory to position the Icahn School of Medicine at Mount Sinai as the leader in cardiovascular genomics.
Laboratories and Core Facilities
Novel therapeutic targets to induce cardiac regeneration post-myocardial infarction.
Atomic Force Microscopy Core Facility
Allowing cutting-edge nanotechnology studies with an atomic force microscope
Cardiovascular Translational Laboratory of Physiology and Imaging
Preclinical testing site for gene and cell transfer
Cardiovascular Cell and Tissue Engineering
Cardiovascular Space and Terrestrial Radiobiology
Making game-changing discoveries related to cardiovascular blockage
Studying adeno-associated virus, a promising gene therapy vector
Targeting pathways to improve cardiac myocyte function and survival
Cardiovascular Exosomes and Epitranscriptome
Molecular mechanisms of cardiomyopathies, gene therapies, clinical trials
Cardiovascular diseases, pulmonary arterial hypertension (PAH), and idiopathic pulmonary fibrosis (IPF).
Systems biology of cardiovascular immunology
Preclinical translational studies using large animals, gene/cell therapy, cardiovascular diseases
Molecular mechanism of heart failure and pulmonary hypertension, tissue engineering
Cardiac fibrosis and immunology
Patient-specific induced pluripotent stem cells (iPSCs) and cardiovascular disease.
Signal transduction in the cardiovascular and pulmonary systems
Translational Studies in Gene Therapy
Tissue Engineering, stem cell biology, inherited and acquired cardiomyopathies